Redhill Biopharma
RDHL
#11160
Rank
โ‚ฌ2.27 M
Marketcap
0,26ย โ‚ฌ
Share price
-13.08%
Change (1 day)
-71.59%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2022: -โ‚ฌ65.34 Million

According to Redhill Biopharma's latest financial reports the company's current earnings are โ‚ฌ35.74 Million. In 2022 the company made an earning of -โ‚ฌ65.34 Million, an increase over its 2021 earnings that were of -โ‚ฌ89.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2022

Annual earnings

Year Earnings Change
2022-โ‚ฌ65.34 Million-26.68%
2021-โ‚ฌ89.11 Million28.32%
2020-โ‚ฌ69.44 Million80.06%
2019-โ‚ฌ38.57 Million8.97%
2018-โ‚ฌ35.39 Million-14.76%
2017-โ‚ฌ41.52 Million55.07%
2016-โ‚ฌ26.78 Million39.26%
2015-โ‚ฌ19.23 Million96.9%
2014-โ‚ฌ9.77 Million0.78%
2013-โ‚ฌ9.69 Million16.93%
2012-โ‚ฌ8.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚ฌ7.09 B 67,200.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ6.12 B 57,997.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ6.52 B 61,725.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.11 B 10,477.26%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚ฌ39.86 M 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel